Oneness Biotech Co (ROCO:4743) Buyback Yield % : -0.19 (As of Apr. 24, 2025)

View and export this data going back to 2011. Start your Free Trial

What is Oneness Biotech Co Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Oneness Biotech Co's current buyback yield was -0.19%.

Oneness Biotech Co Buyback Yield % Historical Data

The historical data trend for Oneness Biotech Co's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oneness Biotech Co Buyback Yield % Chart

Oneness Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Buyback Yield %

Get a 7-Day Free Trial

-6.23

-0.47

-0.36

-0.29

-0.13

Oneness Biotech Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Buyback Yield %	Get a 7-Day Free Trial															-0.29	-0.32	-0.09	-0.10	-0.13

Competitive Comparison of Oneness Biotech Co's Buyback Yield %

For the Biotechnology subindustry, Oneness Biotech Co's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oneness Biotech Co's Buyback Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oneness Biotech Co's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Oneness Biotech Co's Buyback Yield % falls into.

Save Embed

;

Save Embed

;

Oneness Biotech Co Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Oneness Biotech Co's Buyback Yield for the fiscal year that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock			/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	/	Market Cap
	=	- (0	+	54.91)	/	41732.1063
	=	-0.13%

Oneness Biotech Co's annualized Buyback Yield for the quarter that ended in Dec. 2024 is calculated as

Buyback Yield	=	Net Issuance of Stock		(TTM)		/	Market Cap
	=	- (Repurchase of Stock	+	Issuance of Stock)	(TTM)^**	/	Market Cap
	=	- (0	+	54.91)		/	41732.1063
	=	-0.13%

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Oneness Biotech Co Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Oneness Biotech Co's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Oneness Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oneness Biotech Co Ltd (ROCO:4743) » Definitions » Buyback Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Section. 1, Zhongxiao West Road, No. 66, 35th Floor, Zhongzheng District, Taipei, TWN, 100

Website

https://www.onenessbio.com

Oneness Biotech Co Ltd is engaged in the research and development of new drugs, the sale of pharmaceutical products and health products, and other related businesses. It focuses on developing drugs for the treatment of chronic skin and immune diseases. The company's product portfolio comprises FESPIXON cream, for the treatment of diabetic foot ulcers, and also has various other product candidates in its development pipeline, such as FB825, FB704A, SNS812, OB318, and others. Along with its subsidiaries, the company operates in the following reportable segments: New drug research and development, which derives maximum revenue, and the Agricultural products cultivation segment.

Oneness Biotech Co Headlines

No Headlines